Structure and Stability of Human Telomeric G-Quadruplex with Preclinical 9-Amino Acridines

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Ferreira, Ruben ^a   Artali, Roberto ^b   Benoit, Adam ^c   Gargallo, Raimundo ^d   Eritja, Ramon ^a   Ferguson, David M ^c   Sham, Yuk Y ^e   Mazzini, Stefania ^f  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b Scientia Advice di Roberto Artali ^*  (Italy)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOACRIDINE; GUANINE QUADRUPLEX;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; DRUG DNA BINDING; DRUG DNA INTERACTION; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; HUMAN; HYDROGEN BOND; INTERCALATION COMPLEX; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

AMINOACRIDINES; ANTINEOPLASTIC AGENTS; DNA, NEOPLASM; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDROGEN BONDING; MOLECULAR DYNAMICS SIMULATION; NEOPLASMS; TELOMERE;

EID: 84875048234     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057701     Document Type: Article

References (65)

1. Denny WA, (2002) Acridine derivatives as chemotherapeutic agents. Current Medicinal Chemistry 9: 1655-1665.
2. Belmont P, Bosson J, Godet T, Tiano M, (2007) Acridine and acridone derivatives, anticancer properties and synthetic methods: Where are we now? Anti-Cancer Agents in Medicinal Chemistry 7: 139-169.
3. Zahler AM, Williamson JR, Cech TR, Prescott DM, (1991) INHIBITION OF TELOMERASE BY G-QUARTET DNA STRUCTURES. Nature 350: 718-720.
4. Larsen AK, Eseargueil AE, Skladanowski A, (2003) Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacology & Therapeutics 99: 167-181.
5. Corbett KD, Berger JM, (2004) Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. Annual Review of Biophysics and Biomolecular Structure 33: 95-118.
6. Topcu Z, (2001) DNA topoisomerases as targets for anticancer drugs. Journal of Clinical Pharmacy and Therapeutics 26: 405-416.
7. Arimondo PB, Helene C, (2001) Design of new anti-cancer agents based on topoisomerase poisons targeted to specific DNA sequences. Current medicinal chemistry Anti-cancer agents 1: 219-235.
8. Blackburn EH, (2000) Telomere states and cell fates. Nature 408: 53-56.
9. Blackburn EH, (2001) Switching and signaling at the telomere. Cell 106: 661-673.
10. Neidle S, Parkinson G, (2002) Telomere maintenance as a target for anticancer drug discovery. Nature Reviews Drug Discovery 1: 383-393.
11. Mergny JL, Helene C, (1998) G-quadruplex DNA: A target for drug design. Nature Medicine 4: 1366-1367.
12. Cheng MK, Modi C, Cookson JC, Hutchinson I, Heald RA, et al. (2008) Antitumor polycyclic acridines. 20. search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino 4,3,2-kl acridinium salts: Telomere-targeted agents. Journal of Medicinal Chemistry 51: 963-975.
13. Monchaud D, Teulade-Fichou MP, (2008) A hitchhiker's guide to G-quadruplex ligands. Organic & Biomolecular Chemistry 6: 627-636.
14. Goodell JR, Ougolkov AV, Hiasa H, Kaur H, Remmel R, et al. (2008) Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis. Journal of Medicinal Chemistry 51: 179-182.
15. Campbell NH, Patel M, Tofa AB, Ghosh R, Parkinson GN, et al. (2009) Selectivity in Ligand Recognition of G-Quadruplex Loops. Biochemistry 48: 1675-1680.
16. Sun D, Liu WJ, Guo KX, Rusche JJ, Ebbinghaus S, et al. (2008) The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents. Molecular Cancer Therapeutics 7: 880-889.
17. Phan AT, Modi YS, Patel DJ, (2004) Propeller-type parallel-stranded g-quadruplexes in the human c-myc promoter. Journal of the American Chemical Society 126: 8710-8716.
18. Fernando H, Reszka AP, Huppert J, Ladame S, Rankin S, et al. (2006) A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene. Biochemistry 45: 7854-7860.
19. Dai JX, Dexheimer TS, Chen D, Carver M, Ambrus A, et al. (2006) An intramolecular G-quadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution. Journal of the American Chemical Society 128: 1096-1098.
20. Kumari S, Bugaut A, Huppert JL, Balasubramanian S, (2007) An RNA G-quadruplex in the 5′ UTR of the NRAS proto-oncogene modulates translation. Nature Chemical Biology 3: 218-221.
21. Cogoi S, Xodo LE, (2006) G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription. Nucleic Acids Research 34: 2536-2549.
22. Guo K, Pourpak A, Beetz-Rogers K, Gokhale V, Sun D, et al. (2007) Formation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene. Journal of the American Chemical Society 129: 10220-10228.
23. Sun DY, Guo KX, Rusche JJ, Hurley LH, (2005) Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Research 33: 6070-6080.
24. Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH, (2002) Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proceedings of the National Academy of Sciences of the United States of America 99: 11593-11598.
25. Han HY, Hurley LH, (2000) G-quadruplex DNA: a potential target for anti-cancer drug design. Trends in Pharmacological Sciences 21: 136-142.
26. Balasubramanian S, Hurley LH, Neidle S, (2011) Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nature Reviews Drug Discovery 10: 261-275.
27. Goodell JR, Madhok AA, Hiasa H, Ferguson DM, (2006) Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activity. Bioorganic & Medicinal Chemistry 14: 5467-5480.
28. Oppegard LM, Ougolkov AV, Luchini DN, Schoon RA, Goodell JR, et al. (2009) Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II. European Journal of Pharmacology 602: 223-229.
29. Naasani I, Seimiya H, Yamori T, Tsuruo T, (1999) FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Research 59: 4004-4011.
30. Franceschin M, Rossetti L, D'Ambrosio A, Schirripa S, Bianco A, et al. (2006) Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorganic & Medicinal Chemistry Letters 16: 1707-1711.
31. Granotier C, Pennarun G, Riou L, Hoffschir F, Gauthier LR, et al. (2005) Preferential binding of a G-quadruplex ligand to human chromosome ends. Nucleic Acids Research 33: 4182-4190.
32. Ren JS, Chaires JB, (1999) Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry 38: 16067-16075.
33. Ragazzon P, Chaires JB, (2007) Use of competition dialysis in the discovery of G-quadruplex selective ligands. Methods 43: 313-323.
34. Gros J, Rosu F, Amrane S, De Cian A, Gabelica V, et al. (2007) Guanines are a quartet's best friend: impact of base substitutions on the kinetics and stability of tetramolecular quadruplexes. Nucleic Acids Research 35: 3064-3075.
35. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ, (1992) Selection of single-stranded-DNA molecules that bind and inhibit human thrombin Nature. 355: 564-566.
36. Wang Y, Patel DJ, (1993) Solution structure of a parallel-stranded G-quadruplex DNA Journal of Molecular Biology. 234: 1171-1183.
37. Palchaudhuri R, Hergenrother PJ, (2007) DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Current Opinion in Biotechnology 18: 497-503.
38. White EW, Tanious F, Ismail MA, Reszka AP, Neidle S, et al. (2007) Structure-specific recognition of quadruplex DNA by organic cations: Influence of shape, substituents and charge. Biophysical Chemistry 126: 140-153.
39. Wang Y, Patel DJ, (1992) Guanine residues in d(T2AG3) and d(T2G4) form parallel-stranded potassium cation stabilized G-quadruplexes with antiglycosidic torsion angles in solution. Biochemistry 31: 8112-8119.
40. Mazzini S, Mondelli R, Ragg E, (1998) Structure and dynamics of intercalation complexes of anthracyclines with d(CGATCG)(2) and d(CGTACG)(2). 2D-H-1 and P-31 NMR investigations. Journal of the Chemical Society-Perkin Transactions 2: 1983-1991.
41. Ragg E, Mazzini S, Bortolini R, Mongelli N, D'Alessio R, (1998) H-1 NMR investigations on the solution structure of the oligonucleotide 5′-d(ACCT(5)GATGT)-3′/5′-d(ACATCA(5)GGT)-3′ and its interaction with tallimustine. Journal of the Chemical Society-Perkin Transactions 2: 149-158.
42. Mazzini S, Bellucci MC, Dallavalle S, Fraternali F, Mondelli R, (2004) Mode of binding of camptothecins to double helix oligonucleotides. Organic & Biomolecular Chemistry 2: 505-513.
43. Bortolini R, Mazzini S, Mondelli R, Ragg E, Ulbricht C, et al. (1994) P-31 NMR-Studies on the interaction of morpholinyl anthracyclines and relade-compound with d(CGTACG)2- thermodynamic and kinetic-parameters. Applied Magnetic Resonance 7: 71-87.
44. Mazzini S, Scaglioni L, Animati F, Mondelli R, (2010) Interaction between double helix DNA fragments and the new antitumor agent sabarubicin, Men10755. Bioorganic & Medicinal Chemistry 18: 1497-1506.
45. Gorenstein DG, (1994) Conformation and dynamics of DNA and protein-DNA complexes by P-31 NMR. Chemical Reviews 94: 1315-1338.
46. Hounsou C, Guittat L, Monchaud D, Jourdan M, Saettel N, et al. (2007) G-quadruplex recognition by quinacridines: a SAR, NMR, and biological study. Chemmedchem 2: 655-666.
47. Rao L, Dworkin JD, Nell WE, Bierbach U, (2011) Interactions of a Platinum-Modified Perylene Derivative with the Human Telomeric G-Quadruplex. Journal of Physical Chemistry B 115: 13701-13712.
48. Šponer J, Cang X, Cheatham Iii TE Molecular dynamics simulations of G-DNA and perspectives on the simulation of nucleic acid structures. Methods.
49. Ferreira R, Avino A, Perez-Tomas R, Gargallo R, Eritja R (2010) Synthesis and g-quadruplex-binding properties of defined acridine oligomers. Journal of nucleic acids 2010.
50. Kumar A, Ernst RR, Wuthrich K, (1980) A two-dimensional nuclear overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation network in biologial macromolecules. Biochemical and Biophysical Research Communications 95: 1-6.
51. Braunschweiler L, Ernst RR, (1983) Coherence transfer by isotropic mixing- pplication to proton correlation spectroscoyp. Journal of Magnetic Resonance 53: 521-528.
52. T.D. Goddard DGK (2004) SPARKY 3. University of California, San Francisco, USA.
53. Dyson RM, Kaderli S, Lawrance GA, Maeder M, Zunderbuhler AD, (1997) Second order global analysis: the evaluation of series of spectrophotometric titrations for improved determination of equilibrium constants. Analytica Chimica Acta 353: 381-393.
54. Lindahl E, Hess B, van der Spoel D, (2001) GROMACS 3.0: a package for molecular simulation and trajectory analysis. Journal of Molecular Modeling 7: 306-317.
55. Oostenbrink C, Soares TA, van der Vegt NFA, van Gunsteren WF, (2005) Validation of the 53A6 GROMOS force field. European Biophysics Journal with Biophysics Letters 34: 273-284.
56. Stewart JP, (2007) Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements. Journal of Molecular Modeling 13: 1173-1213.
57. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, et al. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry 19: 1639-1662.
58. Huey R, Morris GM, Olson AJ, Goodsell DS, (2007) A semiempirical free energy force field with charge-based desolvation. Journal of Computational Chemistry 28: 1145-1152.
59. Sanner MF, (1999) Python: A programming language for software integration and development. Journal of Molecular Graphics & Modelling 17: 57-61.
60. Gasteiger J, Marsili M, (1980) Iterative partial equalization of orbital electonegativity- a rapid access to atomic charges. Tetrahedron 36: 3219-3228.
61. M. J. Frisch GWT, H. B Schlegel, G. E Scuseria, M. A Robb, J. R Cheeseman et al.(2004) Gaussian 03, Revision C.02. Gaussian, Inc, Wallingford CT.
62. Jorgensen WL, Maxwell DS, TiradoRives J, (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society 118: 11225-11236.
63. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, (1983) Comparison of simple potential function for simulating liquid water Journal of Chemical Physics. 79: 926-935.
64. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A smooth particle mesh ewald method. Journal of Chemical Physics 103: 8577-8593.
65. Ryckaert JP, Ciccotti G, Berendsen HJC, (1977) Numerical-integration of cartesian equations of motion of a system with constraints- molecular-dynamics of N-alkanes. Journal of Computational Physics 23: 327-341.